|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5094941A
(en)
*
|
1987-12-31 |
1992-03-10 |
Zymogenetics, Inc. |
Monoclonal antibodies to PDGF
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
WO1989012624A2
(en)
|
1988-06-14 |
1989-12-28 |
Cetus Corporation |
Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
CA2103059C
(en)
|
1991-06-14 |
2005-03-22 |
Paul J. Carter |
Method for making humanized antibodies
|
|
EP1136556B1
(en)
|
1991-11-25 |
2005-06-08 |
Enzon, Inc. |
Method of producing multivalent antigen-binding proteins
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
US5663149A
(en)
|
1994-12-13 |
1997-09-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
GB2339430A
(en)
|
1997-05-21 |
2000-01-26 |
Biovation Ltd |
Method for the production of non-immunogenic proteins
|
|
EP1958962A3
(en)
|
1997-06-12 |
2013-05-01 |
Novartis International Pharmaceutical Ltd. |
Artificial antibody polypeptides
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
PT1071700E
(pt)
|
1998-04-20 |
2010-04-23 |
Glycart Biotechnology Ag |
Modificação por glicosilação de anticorpos para melhorar a citotoxicidade celular dependente de anticorpos
|
|
WO2000061739A1
(fr)
|
1999-04-09 |
2000-10-19 |
Kyowa Hakko Kogyo Co., Ltd. |
Methode de regulation de l'activite d'une molecule immunologiquement fonctionnelle
|
|
ATE309385T1
(de)
|
2000-06-28 |
2005-11-15 |
Glycofi Inc |
Verfahren für die herstellung modifizierter glykoproteine
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
WO2003026577A2
(en)
|
2001-09-24 |
2003-04-03 |
Seattle Genetics, Inc. |
P-amidobenzylethers in drug delivery agents
|
|
NZ532526A
(en)
|
2001-10-25 |
2007-01-26 |
Genentech Inc |
Compositions comprising a glycoprotein having a Fc region
|
|
JP2005512044A
(ja)
|
2001-12-03 |
2005-04-28 |
アブジェニックス・インコーポレーテッド |
結合特性に基づく抗体分類
|
|
JP4741838B2
(ja)
|
2002-07-31 |
2011-08-10 |
シアトル ジェネティクス，インコーポレーテッド |
癌、自己免疫疾患または感染症を治療するための薬物結合体およびその使用
|
|
CN104998273A
(zh)
|
2003-11-06 |
2015-10-28 |
西雅图基因公司 |
能够与配体偶联的单甲基缬氨酸化合物
|
|
AU2005216251B2
(en)
|
2004-02-23 |
2011-03-10 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
ES2533695T3
(es)
|
2004-03-02 |
2015-04-14 |
Seattle Genetics, Inc. |
Anticuerpos cargados parcialmente y métodos para su conjugación
|
|
EP1626059A1
(en)
|
2004-08-09 |
2006-02-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2
|
|
CA2586909A1
(en)
|
2004-11-12 |
2006-12-14 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the n terminus
|
|
EP1898529A1
(en)
|
2005-06-28 |
2008-03-12 |
Pioneer Corporation |
Broadcast receiving apparatus, interference detecting apparatus and interference detecting method
|
|
PL1912671T3
(pl)
|
2005-07-18 |
2018-02-28 |
Seattle Genetics, Inc. |
Koniugaty beta-glukuronid-linker-lek
|
|
EP1880729A1
(en)
|
2006-07-20 |
2008-01-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of soluble CD160 to suppress immunity
|
|
CL2007003291A1
(es)
*
|
2006-11-15 |
2008-07-04 |
Medarex Inc |
Anticuerpo monoclonal humano aislado que enlaza la proteina btla o fragmentos del mismo; acido nucleico que lo codifica; metodo de produccion; composicion e inmunoconjugado que los comprende; y metodo para inhibir el crecimiento de celulas de tumor e
|
|
EP2006299A1
(en)
|
2007-06-18 |
2008-12-24 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Identification of new isoforms of the MHC-class I specific receptor CD160 and uses thereof
|
|
EP2210903A1
(en)
*
|
2009-01-21 |
2010-07-28 |
Monoclonal Antibodies Therapeutics |
Anti-CD160 monoclonal antibodies and uses thereof
|
|
EP2548030B1
(en)
*
|
2010-03-18 |
2015-05-27 |
Cornell University |
Engineering correctly folded antibodies using inner membrane display of twin-arginine translocation intermediates
|
|
CN107648605A
(zh)
*
|
2010-05-28 |
2018-02-02 |
国家医疗保健研究所 |
用于治疗基于新血管生成的眼部疾病的抗‑cd160特异性抗体
|
|
US9676871B2
(en)
|
2010-11-05 |
2017-06-13 |
Pfizer Inc. |
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
|
|
WO2013072714A1
(en)
*
|
2011-11-15 |
2013-05-23 |
Centre National De La Recherche Scientifique (Cnrs) |
Antibodies for molecular imaging of vulnerable plaques in atherosclerosis
|
|
EP3245228A1
(en)
|
2015-01-16 |
2017-11-22 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Human monoclonal antibodies against orexin receptor type 1
|